New Weight-Loss drug begins human testing
NCT ID NCT07184502
Summary
This is the first human study of an experimental injection called ZT003. Researchers will test different doses in 76 healthy and overweight volunteers to see if it's safe and how the body processes it. The goal is to gather basic safety information to guide future studies in people with obesity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network Brisbane
RECRUITINGBrisbane, Queensland, Australia
Contact
Conditions
Explore the condition pages connected to this study.